Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_000533.4(PLP1):c.-31C>T | 5354 | PLP1 | Benign | 2233695 | RCV000204678; | N | MedGen:C1839264,OMIM:312920,ORPHA:99015 | X | 103031893 | 103031893 | NM_000533.4:c.-31C>T | | NC_000023.10:g.103031893C>T | - | C1839264 312920 Spastic paraplegia 2 | | |
NM_000533.4(PLP1):c.2T>C (p.Met1Thr) | 5354 | PLP1 | Pathogenic | 864622194 | RCV000203805; | N | MedGen:C1839264,OMIM:312920,ORPHA:99015 | X | 103031925 | 103031925 | NM_000533.4:c.2T>C | NP_000524.3:p.Met1Thr | NC_000023.10:g.103031925T>C | - | C1839264 312920 Spastic paraplegia 2 | | |
NM_000533.4(PLP1):c.168A>G (p.Gln56=) | 5354 | PLP1 | Benign | 2233697 | RCV000206003; RCV000117996; | N | MedGen:C1839264,OMIM:312920,ORPHA:99015; MedGen:CN169374 | X | 103040674 | 103040674 | NM_000533.4:c.168A>G | NP_000524.3:p.Gln56= | NC_000023.10:g.103040674A>G | - | CN169374 not specified; C1839264 312920 Spastic paraplegia 2 | | |
NM_001128834.2(PLP1):c.409C>T (p.Arg137Trp) | 5354 | PLP1 | Pathogenic | 132630295 | RCV000011847; | N | MedGen:C1839264,OMIM:312920,ORPHA:99015 | X | 103041611 | 103041611 | NM_001128834.2:c.409C>T | NP_001122306.1:p.Arg137Trp | NC_000023.10:g.103041611C>T | OMIM Allelic Variant:300401.0026 | C1839264 312920 Spastic paraplegia 2 | | |
NM_001128834.2(PLP1):c.418C>T (p.His140Tyr) | 5354 | PLP1 | Pathogenic | 132630287 | RCV000011833; | N | MedGen:C1839264,OMIM:312920,ORPHA:99015 | X | 103041620 | 103041620 | NM_001128834.2:c.418C>T | NP_001122306.1:p.His140Tyr | NC_000023.10:g.103041620C>T | OMIM Allelic Variant:300401.0012 | C1839264 312920 Spastic paraplegia 2 | | |
NM_001128834.2(PLP1):c.509C>T (p.Ser170Phe) | 5354 | PLP1 | Pathogenic | 132630294 | RCV000011841; | N | MedGen:C1839264,OMIM:312920,ORPHA:99015 | X | 103042782 | 103042782 | NM_001128834.2:c.509C>T | NP_001122306.1:p.Ser170Phe | NC_000023.10:g.103042782C>T | OMIM Allelic Variant:300401.0020 | C1839264 312920 Spastic paraplegia 2 | | |
NM_001128834.2(PLP1):c.560T>C (p.Ile187Thr) | 5354 | PLP1 | Pathogenic | 132630288 | RCV000011834; | N | MedGen:C1839264,OMIM:312920,ORPHA:99015 | X | 103042833 | 103042833 | NM_001128834.2:c.560T>C | NP_001122306.1:p.Ile187Thr | NC_000023.10:g.103042833T>C | OMIM Allelic Variant:300401.0013 | C1839264 312920 Spastic paraplegia 2 | | |
NM_001128834.2(PLP1):c.710T>C (p.Phe237Ser) | 5354 | PLP1 | Pathogenic | 132630291 | RCV000011838; | N | MedGen:C1839264,OMIM:312920,ORPHA:99015 | X | 103044275 | 103044275 | NM_001128834.2:c.710T>C | NP_001122306.1:p.Phe237Ser | NC_000023.10:g.103044275T>C | OMIM Allelic Variant:300401.0017 | C1839264 312920 Spastic paraplegia 2 | | |